Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMASCIS-02: Allogeneic Adipose Tissue-derived MSCs in Ischemic Stroke
NCT04280003Phase 2Unknown
- Sponsor
- Hospital La Paz Institute for Health Research
- Start
- Jan 2021
- Primary completion
- Jul 2023
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of allogeneic adipose tissue-derived mesenchymal stem cells in ischemic stroke, sponsored by Hospital La Paz Institute for Health Research. Status: unknown.
02
Drugs
allogeneic adipose tissue-derived mesenchymal stem cells
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT04280003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04280003.